BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

$1.1B

Market Cap • 4/2/2025

2019

(6 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of CN

Chengdu

Headquarters